Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Shares Repurchased (2020 - 2025)

Historic Shares Repurchased for Roivant Sciences (ROIV) over the last 5 years, with Q2 2025 value amounting to $208.3 million.

  • Roivant Sciences' Shares Repurchased fell 6787.51% to $208.3 million in Q2 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year decrease of 3116.87%. This contributed to the annual value of $1.3 billion for FY2025, which is N/A changed from last year.
  • Latest data reveals that Roivant Sciences reported Shares Repurchased of $208.3 million as of Q2 2025, which was down 6787.51% from $997.8 million recorded in Q4 2024.
  • In the past 5 years, Roivant Sciences' Shares Repurchased registered a high of $997.8 million during Q4 2024, and its lowest value of -$8.3 million during Q3 2022.
  • In the last 4 years, Roivant Sciences' Shares Repurchased had a median value of $57.2 million in 2022 and averaged $245.6 million.
  • In the last 5 years, Roivant Sciences' Shares Repurchased skyrocketed by 20529.52% in 2021 and then crashed by 47067.2% in 2022.
  • Quarter analysis of 4 years shows Roivant Sciences' Shares Repurchased stood at $2.2 million in 2021, then tumbled by 470.67% to -$8.3 million in 2022, then soared by 12079.67% to $997.8 million in 2024, then plummeted by 79.12% to $208.3 million in 2025.
  • Its last three reported values are $208.3 million in Q2 2025, $997.8 million for Q4 2024, and $106.1 million during Q3 2024.